Eversept Partners, LP Gossamer Bio, Inc. Transaction History

Eversept Partners, LP

$904 Million
Q1 2025

A detailed history of Eversept Partners, LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 3,896,841 shares of GOSS stock, worth $4.09 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

3,896,841

Previous 4,978,458 21.73%

Holding current value

$4.09 Million

Previous $4.48 Million 4.33%

% of portfolio

0.47%

Previous 0.45%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.85 - $1.53 $919,374 - $1.65 Million	-1,081,617 Reduced 21.73%	3,896,841 $4.29 Million
Q3 2024 Nov 14, 2024	SELL	$0.79 - $1.25 $399,495 - $632,112	-505,690 Reduced 9.22%	4,978,458 $4.93 Million
Q2 2024 Aug 14, 2024	SELL	$0.51 - $1.27 $260,265 - $648,111	-510,324 Reduced 8.51%	5,484,148 $4.94 Million
Q1 2024 May 15, 2024	SELL	$0.8 - $1.51 $350,594 - $661,746	-438,243 Reduced 6.81%	5,994,472 $7.07 Million
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $962,331 - $2.17 Million	2,004,858 Added 45.28%	6,432,715 $5.85 Million
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $2.87 Million - $6.69 Million	3,678,160 Added 490.62%	4,427,857 $3.68 Million
Q2 2023 Nov 08, 2023	SELL	$0.98 - $1.53 $590,320 - $921,623	-602,368 Reduced 44.55%	749,697 $899,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $590,320 - $921,623	-602,368 Reduced 44.55%	749,697 $899,000
Q1 2023 Nov 08, 2023	BUY	$0.96 - $2.92 $1.15 Million - $3.5 Million	1,197,853 Added 776.76%	1,352,065 $1.7 Million
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $1.15 Million - $3.5 Million	1,197,853 Added 776.76%	1,352,065 $1.7 Million
Q4 2022 Nov 08, 2023	SELL	$1.74 - $12.87 $685,941 - $5.07 Million	-394,219 Reduced 71.88%	154,212 $334,000
Q4 2022 Feb 14, 2023	SELL	$1.74 - $12.87 $685,941 - $5.07 Million	-394,219 Reduced 71.88%	154,212 $334,000
Q3 2022 Nov 08, 2023	BUY	$7.21 - $14.88 $577,722 - $1.19 Million	80,128 Added 17.11%	548,431 $6.57 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $577,722 - $1.19 Million	80,128 Added 17.11%	548,431 $6.57 Million
Q2 2022 Nov 08, 2023	BUY	$5.97 - $9.97 $558,672 - $932,992	93,580 Added 24.97%	468,303 $3.92 Million
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $558,672 - $932,992	93,580 Added 24.97%	468,303 $3.92 Million
Q1 2022 Nov 08, 2023	SELL	$8.44 - $12.49 $3.16 Million - $4.68 Million	-374,974 Reduced 50.02%	374,723 $3.25 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $2.83 Million - $4.18 Million	334,813 Added 838.92%	374,723 $3.25 Million
Q4 2021 Nov 08, 2023	SELL	$10.12 - $14.07 $1.11 Million - $1.55 Million	-110,000 Reduced 73.38%	39,910 $451,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $1.11 Million - $1.55 Million	-110,000 Reduced 73.38%	39,910 $451,000
Q3 2021 Nov 08, 2023	SELL	$7.25 - $13.23 $4.35 Million - $7.94 Million	-599,787 Reduced 80.0%	149,910 $1.88 Million
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $1.09 Million - $1.98 Million	149,910 New	149,910 $1.88 Million

Others Institutions Holding GOSS

# of Institutions

122

Shares Held

160M

Call Options Held

2.11M

Put Options Held

57.8K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $98.7M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account

Eversept Partners, LP Gossamer Bio, Inc. Transaction History